Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
Urine bisphenol-A (BPA) level in relation to semen qualityLi, De-Kun, M.D., Ph.D ; Zhou, ZhiJun, M.D., Ph.D ; Miao, Maohua, Ph.D ; He, Yonghua, Ph.D ; Wang, JinTao, Ph.D ; Ferber, Jeannette, M.P.H ; Herrinton, Lisa J., Ph.D ; Gao, ErSheng, M.D., M.P.H ; Yuan, Wei, M.D., Ph.DFertility and sterility, 2011-02, Vol.95 (2), p.625-630.e4 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
12 |
Material Type: Artigo
|
![]() |
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patientsEggemann, Holm ; Ignatov, Atanas ; Smith, Bobbie J. ; Altmann, Udo ; von Minckwitz, Gunter ; Röhl, Freidrich W. ; Jahn, Mark ; Costa, Serban-DanBreast cancer research and treatment, 2013-01, Vol.137 (2), p.465-470 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
13 |
Material Type: Artigo
|
![]() |
Relationship between semen production and medical comorbidityEisenberg, Michael L., M.D ; Li, Shufeng, M.S ; Behr, Barry, Ph.D ; Pera, Renee Reijo, Ph.D ; Cullen, Mark R., M.DFertility and sterility, 2015-01, Vol.103 (1), p.66-71 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
14 |
Material Type: Artigo
|
![]() |
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research GroupConnolly, Roisin M ; Zhao, Fengmin ; Miller, Kathy D ; Lee, Min-Jung ; Piekarz, Richard L ; Smith, Karen L ; Brown-Glaberman, Ursa A ; Winn, Jennifer S ; Faller, Bryan A ; Onitilo, Adedayo A ; Burkard, Mark E ; Budd, George T ; Levine, Ellis G ; Royce, Melanie E ; Kaufman, Peter A ; Thomas, Alexandra ; Trepel, Jane B ; Wolff, Antonio C ; Sparano, Joseph AJournal of clinical oncology, 2021-10, Vol.39 (28), p.3171-3181 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
15 |
Material Type: Artigo
|
![]() |
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome AtlasHuo, Dezheng ; Hu, Hai ; Rhie, Suhn K ; Gamazon, Eric R ; Cherniack, Andrew D ; Liu, Jianfang ; Yoshimatsu, Toshio F ; Pitt, Jason J ; Hoadley, Katherine A ; Troester, Melissa ; Ru, Yuanbin ; Lichtenberg, Tara ; Sturtz, Lori A ; Shelley, Carl S ; Benz, Christopher C ; Mills, Gordon B ; Laird, Peter W ; Shriver, Craig D ; Perou, Charles M ; Olopade, Olufunmilayo IJAMA oncology, 2017-12, Vol.3 (12), p.1654-1662 [Periódico revisado por pares]United States: American Medical AssociationTexto completo disponível |
16 |
Material Type: Artigo
|
![]() |
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast CancerBardia, Aditya ; Mayer, Ingrid A ; Diamond, Jennifer R ; Moroose, Rebecca L ; Isakoff, Steven J ; Starodub, Alexander N ; Shah, Nikita C ; O'Shaughnessy, Joyce ; Kalinsky, Kevin ; Guarino, Michael ; Abramson, Vandana ; Juric, Dejan ; Tolaney, Sara M ; Berlin, Jordan ; Messersmith, Wells A ; Ocean, Allyson J ; Wegener, William A ; Maliakal, Pius ; Sharkey, Robert M ; Govindan, Serengulam V ; Goldenberg, David M ; Vahdat, Linda TJournal of clinical oncology, 2017-07, Vol.35 (19), p.2141-2148 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
17 |
Material Type: Artigo
|
![]() |
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trialKrop, Ian E, Dr ; Kim, Sung-Bae, Prof ; Martin, Antonio Gonzalez, MD ; LoRusso, Patricia M, Prof ; Ferrero, Jean-Marc, MD ; Badovinac-Crnjevic, Tanja, MD ; Hoersch, Silke, MSc ; Smitt, Melanie, MD ; Wildiers, Hans, ProfThe lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
18 |
Material Type: Artigo
|
![]() |
Genomic Characterization of de novo Metastatic Breast CancerGarrido-Castro, Ana C ; Spurr, Liam F ; Hughes, Melissa E ; Li, Yvonne Y ; Cherniack, Andrew D ; Kumari, Priti ; Lloyd, Maxwell R ; Bychkovsky, Brittany ; Barroso-Sousa, Romualdo ; Di Lascio, Simona ; Jain, Esha ; Files, Janet ; Mohammed-Abreu, Ayesha ; Krevalin, Max ; MacKichan, Colin ; Barry, William T ; Guo, Hao ; Xia, Daniel ; Cerami, Ethan ; Rollins, Barrett J ; MacConaill, Laura E ; Lindeman, Neal I ; Krop, Ian E ; Johnson, Bruce E ; Wagle, Nikhil ; Winer, Eric P ; Dillon, Deborah A ; Lin, Nancy UClinical cancer research, 2021-02, Vol.27 (4), p.1105-1118 [Periódico revisado por pares]United StatesTexto completo disponível |
19 |
Material Type: Artigo
|
![]() |
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trialDiéras, Véronique, Dr ; Miles, David, Prof ; Verma, Sunil, MD ; Pegram, Mark, Prof ; Welslau, Manfred, MD ; Baselga, José, MD ; Krop, Ian E, MD ; Blackwell, Kim, Prof ; Hoersch, Silke, MSc ; Xu, Jin, PhD ; Green, Marjorie, MD ; Gianni, Luca, MDThe lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
20 |
Material Type: Artigo
|
![]() |
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II studyHan, H.S. ; Diéras, V. ; Robson, M. ; Palácová, M. ; Marcom, P.K. ; Jager, A. ; Bondarenko, I. ; Citrin, D. ; Campone, M. ; Telli, M.L. ; Domchek, S.M. ; Friedlander, M. ; Kaufman, B. ; Garber, J.E. ; Shparyk, Y. ; Chmielowska, E. ; Jakobsen, E.H. ; Kaklamani, V. ; Gradishar, W. ; Ratajczak, C.K. ; Nickner, C. ; Qin, Q. ; Qian, J. ; Shepherd, S.P. ; Isakoff, S.J. ; Puhalla, S.Annals of oncology, 2018-01, Vol.29 (1), p.154-161 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |